Henry Schein (HSIC) | Financial Analysis & Statements
Henry Schein Inc. Mid-cap Healthcare
TL;DR: Financial Overview - Revenue, Profits & Key Metrics
Latest Quarterly: Dec 2025Income Metrics
Revenue
3.4B
Gross Profit
1.1B
30.93%
Operating Income
186.0M
5.41%
Net Income
103.0M
3.00%
EPS (Diluted)
$0.85
Balance Sheet Metrics
Total Assets
11.2B
Total Liabilities
6.4B
Shareholders Equity
4.8B
Debt to Equity
1.34
Cash Flow Metrics
Operating Cash Flow
118.0M
Free Cash Flow
324.0M
Revenue & Profitability Trend
Quarter Income Flow
Dec 31, 2025
Annual Income Flow
2025
Henry Schein Income Statement From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | 13.2B | 12.7B | 12.3B | 12.6B | 12.4B |
| Cost of Goods Sold | 9.1B | 8.7B | 8.5B | 8.8B | 8.7B |
| Gross Profit | 4.1B | 4.0B | 3.9B | 3.8B | 3.7B |
| Gross Margin % | 31.1% | 31.7% | 31.3% | 30.3% | 29.6% |
| Operating Expenses | |||||
| Research & Development | - | - | - | - | - |
| Selling, General & Administrative | 3.1B | 3.0B | 3.0B | 2.8B | 2.6B |
| Other Operating Expenses | - | - | - | - | - |
| Total Operating Expenses | 3.1B | 3.0B | 3.0B | 2.8B | 2.6B |
| Operating Income | 758.0M | 731.0M | 695.0M | 878.0M | 860.0M |
| Operating Margin % | 5.7% | 5.8% | 5.6% | 6.9% | 6.9% |
| Non-Operating Items | |||||
| Interest Income | 33.0M | 24.0M | 17.0M | 8.0M | 6.0M |
| Interest Expense | 150.0M | 131.0M | 87.0M | 35.0M | 27.0M |
| Other Non-Operating Income | -108.0M | -111.0M | -83.0M | -130.0M | -8.0M |
| Pre-tax Income | 533.0M | 513.0M | 542.0M | 721.0M | 831.0M |
| Income Tax | 126.0M | 128.0M | 120.0M | 170.0M | 198.0M |
| Effective Tax Rate % | 23.6% | 25.0% | 22.1% | 23.6% | 23.8% |
| Net Income | 419.0M | 398.0M | 436.0M | 566.0M | 660.0M |
| Net Margin % | 3.2% | 3.1% | 3.5% | 4.5% | 5.3% |
| Key Metrics | |||||
| EBITDA | 1.1B | 1.0B | 957.0M | 1.1B | 1.1B |
| EPS (Basic) | - | $3.07 | $3.18 | $3.95 | $4.51 |
| EPS (Diluted) | - | $3.05 | $3.16 | $3.91 | $4.45 |
| Basic Shares Outstanding | - | 126788997 | 130618990 | 136064221 | 140091000 |
| Diluted Shares Outstanding | - | 126788997 | 130618990 | 136064221 | 140091000 |
Income Statement Trend
Join Our United States Telegram Channel
Get Instant Market Updates: 52-Week High/Low Alerts, Breakout Notifications & Expert Stock Analysis Delivered To Your Phone. Join Traders Making Informed Decisions Daily!
Henry Schein Balance Sheet From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Assets | |||||
| Current Assets | |||||
| Cash & Equivalents | 156.0M | 122.0M | 171.0M | 117.0M | 118.0M |
| Short-term Investments | - | - | - | - | - |
| Accounts Receivable | 1.7B | 1.5B | 1.9B | 1.4B | 1.5B |
| Inventory | 2.0B | 1.8B | 1.8B | 2.0B | 1.9B |
| Other Current Assets | 655.0M | 569.0M | 639.0M | 466.0M | 413.0M |
| Total Current Assets | 4.5B | 4.0B | 4.5B | 4.0B | 3.8B |
| Non-Current Assets | |||||
| Property, Plant & Equipment | 301.0M | 293.0M | 325.0M | 284.0M | 325.0M |
| Goodwill | 9.4B | 8.8B | 8.7B | 6.4B | 6.4B |
| Intangible Assets | 1.0B | 1.0B | 916.0M | 587.0M | 668.0M |
| Long-term Investments | - | - | - | - | - |
| Other Non-Current Assets | 353.0M | 255.0M | 234.0M | 272.0M | 218.0M |
| Total Non-Current Assets | 6.8B | 6.2B | 6.1B | 4.6B | 4.6B |
| Total Assets | 11.2B | 10.2B | 10.6B | 8.6B | 8.5B |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts Payable | 1.2B | 962.0M | 1.0B | 1.0B | 1.1B |
| Short-term Debt | 875.0M | 781.0M | 494.0M | 182.0M | 138.0M |
| Current Portion of Long-term Debt | - | - | - | - | - |
| Other Current Liabilities | - | - | - | - | - |
| Total Current Liabilities | 3.2B | 2.8B | 2.7B | 2.2B | 2.3B |
| Non-Current Liabilities | |||||
| Long-term Debt | 2.6B | 2.1B | 2.2B | 1.3B | 1.1B |
| Deferred Tax Liabilities | 146.0M | 102.0M | 54.0M | 36.0M | 42.0M |
| Other Non-Current Liabilities | 486.0M | 387.0M | 436.0M | 361.0M | 377.0M |
| Total Non-Current Liabilities | 3.2B | 2.6B | 2.7B | 1.7B | 1.5B |
| Total Liabilities | 6.4B | 5.4B | 5.4B | 3.9B | 3.8B |
| Equity | |||||
| Common Stock | 1.0M | 1.0M | 1.0M | 1.0M | 1.0M |
| Retained Earnings | 3.3B | 3.8B | 3.9B | 3.7B | 3.6B |
| Treasury Stock | - | - | - | - | - |
| Other Equity | - | - | - | - | - |
| Total Shareholders Equity | 4.8B | 4.8B | 5.2B | 4.7B | 4.7B |
| Key Metrics | |||||
| Total Debt | 3.4B | 2.9B | 2.7B | 1.5B | 1.2B |
| Working Capital | 1.2B | 1.2B | 1.8B | 1.8B | 1.5B |
Balance Sheet Composition
Henry Schein Cash Flow Statement From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net Income | 419.0M | 398.0M | 436.0M | 566.0M | 660.0M |
| Depreciation & Amortization | 281.0M | 268.0M | 248.0M | 212.0M | 210.0M |
| Stock-Based Compensation | 39.0M | 39.0M | 39.0M | 54.0M | 78.0M |
| Working Capital Changes | -264.0M | 303.0M | -234.0M | -185.0M | -282.0M |
| Operating Cash Flow | 435.0M | 957.0M | 503.0M | 659.0M | 643.0M |
| Investing Activities | |||||
| Capital Expenditures | -139.0M | -148.0M | -147.0M | -96.0M | -79.0M |
| Acquisitions | -199.0M | -230.0M | -955.0M | -158.0M | -561.0M |
| Investment Purchases | - | - | - | - | - |
| Investment Sales | 0 | 0 | 22.0M | 0 | 0 |
| Investing Cash Flow | -348.0M | -391.0M | -1.1B | -244.0M | -644.0M |
| Financing Activities | |||||
| Share Repurchases | -850.0M | -385.0M | -250.0M | -485.0M | -401.0M |
| Dividends Paid | - | - | - | - | - |
| Debt Issuance | 489.0M | 120.0M | 1.4B | 270.0M | 305.0M |
| Debt Repayment | -44.0M | -318.0M | -468.0M | -59.0M | -122.0M |
| Financing Cash Flow | -190.0M | -516.0M | 700.0M | -317.0M | -333.0M |
| Free Cash Flow | 521.0M | 661.0M | 313.0M | 474.0M | 598.0M |
| Net Change in Cash | -103.0M | 50.0M | 108.0M | 98.0M | -334.0M |
Cash Flow Trend
Henry Schein Key Financial Ratios
Valuation Ratios
P/E Ratio (TTM)
23.94
Forward P/E
13.30
Price to Book
2.79
Price to Sales
0.68
PEG Ratio
1.63
Profitability Ratios
Profit Margin
3.02%
Operating Margin
5.30%
Return on Equity
8.70%
Return on Assets
4.33%
Financial Health
Current Ratio
1.38
Debt to Equity
71.74
Beta
0.88
Per Share Data
EPS (TTM)
$3.27
Book Value per Share
$28.03
Revenue per Share
$109.13
Peer Financial Comparison
| Company | Market Cap | P/E Ratio | P/B Ratio | ROE | Profit Margin | Debt/Equity |
|---|---|---|---|---|---|---|
| HSIC | 9.0B | 23.94 | 2.79 | 8.70% | 3.02% | 71.74 |
| McKesson | 103.2B | 24.33 | -1,040.14 | -194.51% | 1.09% | -88.23 |
| Cencora | 60.6B | 37.46 | 31.84 | 133.47% | 0.50% | 472.58 |
| Patterson Companies | 2.8B | 20.48 | 2.80 | 14.11% | 2.13% | 88.87 |
| Cardinal Health | 48.2B | 29.50 | -17.89 | -59.26% | 0.68% | -3.34 |
| Owens & Minor | 184.1M | - | - | -196.39% | -12.45% | -4.86 |
Financial data is updated regularly. All figures are in the company's reporting currency.





